Tectonic Therapeutic, Inc. (TECX) key performance indicators and operating metrics (3 metrics) from SEC EDGAR filings, earnings calls, and investor decks. First-party data.
| Metric | Latest Value | Period |
|---|---|---|
| Cardiac Output Improvement (TX45 Phase 1b Part B) | 17.30 percent | FY2025-Q4 |
| Number of Patients in TX45 Phase 1b Part B (Group 2 Pulmonary Hypertension in Heart Failure with Reduced Ejection Fraction) | 14.00 | FY2025-Q4 |
| Pulmonary Capillary Wedge Pressure Reduction (TX45 Phase 1b Part B) | 29.20 percent | FY2025-Q4 |
Back to TECX overview · TECX earnings · TECX holders
Data sourced from U.S. SEC EDGAR filings, earnings call transcripts, and investor decks. Not personalized investment advice.